Source author record

Pierre-Alexandre Bliman

Pierre-Alexandre Bliman appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

math.OC eess.SY math.DS math.NA physics.soc-ph Populations and Evolution Systems and Control

Catalog footprint

What is connected

4works

7topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2022arXiv

Modelling, Analysis, Observability and Identifiability of Epidemic Dynamics with Reinfections

We consider in this paper a general SEIRS model describing the dynamics of an infectious disease including latency, waning immunity and infection-induced mortality. We derive an infinite system of differential equations that provides an image of the same infection process, but counting also the reinfections. Existence and uniqueness of the corresponding Cauchy problem is established in a suitable space of sequence valued functions, and the asymptotic behavior of the solutions is characterized, according to the value of the basic reproduction number. This allows to determine several mean numbers of reinfections related to the population at endemic equilibrium. We then show how using jointly measurement of the number of infected individuals and of the number of primo-infected provides observability and identifiability to a simple SIS model for which none of these two measures is sufficient to ensure on its own the same properties.

preprint2021arXiv

Modeling and Control of Epidemics through Testing Policies

Testing is a crucial control mechanism in the beginning phase of an epidemic when the vaccines are not yet available. It enables the public health authority to detect and isolate the infected cases from the population, thereby limiting the disease transmission to susceptible people. However, despite the significance of testing in epidemic control, the recent literature on the subject lacks a control-theoretic perspective. In this paper, an epidemic model is proposed that incorporates the testing rate as a control input and differentiates the undetected infected from the detected infected cases, who are assumed to be removed from the disease spreading process in the population. After estimating the model on the data corresponding to the beginning phase of COVID-19 in France, two testing policies are proposed: the so-called best-effort strategy for testing (BEST) and constant optimal strategy for testing (COST). The BEST policy is a suppression strategy that provides a minimum testing rate that stops the growth of the epidemic when implemented. The COST policy, on the other hand, is a mitigation strategy that provides an optimal value of testing rate minimizing the peak value of the infected population when the total stockpile of tests is limited. Both testing policies are evaluated by their impact on the number of active intensive care unit (ICU) cases and the cumulative number of deaths for the COVID-19 case of France.

preprint2020arXiv

Optimal immunity control by social distancing for the SIR epidemic model

Until a vaccine or therapy is found against the SARS-CoV-2 coronavirus, reaching herd immunity appears to be the only mid-term option. However, if the number of infected individuals decreases and eventually fades only beyond this threshold, a significant proportion of susceptible may still be infected until the epidemic is over. A containment strategy is likely the best policy in the worst case where no vaccine or therapy is found. In order to keep the number of newly infected persons to a minimum, a possible strategy is to apply strict containment measures, so that the number of susceptible individuals remains close to herd immunity. Such an action is unrealistic since containment can only last for a finite amount of time and is never total. In this article, using a classical SIR model, we determine the (partial or total) containment strategy on a given finite time interval that maximizes the number of susceptible individuals over an infinite horizon, or equivalently that minimizes the total infection burden during the curse of the epidemic. The existence and uniqueness of the optimal strategy is proved and the latter is fully characterized. If applicable in practice, such a strategy would lead theoretically to an increase by 30% of the proportion of susceptible on an infinite horizon, for a containment level corresponding to the sanitary measures put in place in France from March to May 2020. We also analyze the minimum intervention time to reach a fixed distance from herd immunity, and show the relationship with the previous problem. Simulations are provided that illustrate and validate the theoretical results.

preprint2012arXiv

A cooperative conjugate gradient method for linear systems permitting multithread implementation of low complexity

This paper proposes a generalization of the conjugate gradient (CG) method used to solve the equation $Ax=b$ for a symmetric positive definite matrix $A$ of large size $n$. The generalization consists of permitting the scalar control parameters (= stepsizes in gradient and conjugate gradient directions) to be replaced by matrices, so that multiple descent and conjugate directions are updated simultaneously. Implementation involves the use of multiple agents or threads and is referred to as cooperative CG (cCG), in which the cooperation between agents resides in the fact that the calculation of each entry of the control parameter matrix now involves information that comes from the other agents. For a sufficiently large dimension $n$, the use of an optimal number of cores gives the result that the multithread implementation has worst case complexity $O(n^{2+1/3})$ in exact arithmetic. Numerical experiments, that illustrate the interest of theoretical results, are carried out on a multicore computer.